Impact of the pandemic on routine immunisations for vaccine-preventable diseases
Routine childhood immunisation programmes have been disrupted because of Covid-19 and their implementation should be prioritised.
Country Risk Report Q4 2021 - Professional Services
Trial Activity Snapshot: Did Australia’s “zero-Covid” plan protect clinical trial activity?
Moderna eyes combined Covid-19, flu booster by 2023
HDT Bio dose first subjects in Phase I Covid-19 vaccine trial
Bod Australia to start long Covid-19 trial using medicinal cannabis in UK
Novartis and Molecular Partners report positive antiviral trial data
SAHPRA grants approval to begin trial of PaxMedica’s long Covid-19 therapy
J&J’s Covid-19 vaccine offers protection against breakthrough infections
